En el segundo trimestre de 2020, el volumen de fusiones y adquisiciones en el sector aumentó un 25% respecto a la primera mitad del año y un 14% si lo comparamos con el conjunto de 2019. El valor de...
El Fondo Español Columbus Life Science y el inglés Advent Life Science han liderado una ronda de inversión de 22,6 millones de euros en la empresa biotecnológica Highlight Therapeutics, que ha con...
Koa Health, a digital mental healthcare provider offering personalized solutions backed by science, today announced it closed an oversubscribed €30 million ($36 million) Series A funding round. The ...
Kurma Partners joined the round which includes and was initially led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors And...
The Riverside Company, a global private equity firm focused on the smaller end of the middle market, has invested in iTakeControl (ITC), a leading provider of clinical operations and medical affairs t...
El compromiso adquirido con las gestoras es que los 10 millones de euros logren multiplicar por cinco la inversión hasta alcanzar los 50 millones de euros. El dinero se desembolsará a medida que los...
GENESIS Biomed, a consulting company specialized in R + D projects in biomedicine, has recently established its Business Advisory Board, a multidisciplinary panel of experts, KOL in their respective s...
The Group has signed an agreement to acquire Ita Mental Health a group specialised in mental health with 39 facilities across Spain. Ita Mental Health is the third largest player in Spainby number of ...
Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the closing of an oversubsc...
Miura Private Equity reached an agreement to invest in Proclinic, the largest specialized distributor of odontology solutions in Spain, with the aim of strengthening its leadership in Spain, boosting ...
Gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by LAVA, are expected to be $100.5 million. The offering is expected to clos...
The company announces a €14.35M Series A, one of the biggest rounds in the Spanish medtech industry, co-led by Asabys Partners and Alta Life Sciences, joined by CDTI Innvierte and two international ...